Using a combination of stem cell biology, systems biology, synthetic biology, and chromatin engineering, the Galloway lab will define the molecular regulatory rules of cell-fate transitions.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Study suggests this process for eliminating unneeded cells may also protect against cancer.
Deterministic lateral displacement assay can rapidly assess host inflammatory response, identifying a potentially life-threatening hyper-aggressive immune response.
Tough as plastic wrap but elastic like a balloon, the lining could be a target for therapies to limit cancer cells from spreading.
Oocyte growth relies on physical phenomena that drive smaller cells to dump their contents into a larger cell.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
Study suggests forcing bacteria to burn more energy could make them more susceptible to antibiotics.
Case’s new lab investigates why cancer arises when disruptions in cellular organization change how cells sense mechanical forces.
Using CRISPR technology, researchers are tracking the lineage of individual cancer cells as they proliferate and metastasize in real-time.
MIT study sheds light on the longstanding question of why cancer cells get their energy from fermentation.
Unbiased, high-throughput analysis pipeline improves utility of “minibrains” for understanding development and diseases such as Zika infection.
M-CELS are purpose-driven living systems with multiple interacting living components.
Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers.
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.